ReviewFrontiers in oncology2022

Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers.

Nicholas J Ede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.